← Back to All Filings

Viatris Director James Kilts Acquires 24,835 Shares via RSU Vesting

Low SignificanceMarch 10, 2026 at 7:18:10 PM EDT

Viatris Inc

$VTRS4CIK: 0001792044

Subscribe to track VTRS

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Viatris Director James Kilts Acquires 24,835 Shares via RSU Vesting

Company: Viatris Inc (VTRS) Form: 4 | Filed: 2026-03-10 Significance: Low

Insider: KILTS JAMES M Title: Director | Relationship: Director

Transaction: • Type: RSU Vesting/Exercise • Shares: 24,835 • Price: $0.00 • Value: $0 (Compensation) • Owned After: 161,257

Key Insight: Routine director compensation event involving the vesting of Restricted Stock Units and Dividend Equivalents. No open market activity.

Market Context: Viatris has a market cap of $17.19B; this transaction represents 0.002% of shares outstanding.

View Full Filing

Comprehensive Analysis

SEC Filing Analysis: Viatris Inc (VTRS)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: Routine vesting of director compensation (RSUs) and dividend equivalents; no open market purchases or sales.
  • Market Impact: Neutral - This is a scheduled non-market event with negligible dilution.

Company Information

FieldValue
CompanyViatris Inc
Ticker SymbolVTRS
CIK0001792044
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameKILTS JAMES M
CIK0001025094
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2026-03-06
Transaction CodeM (Exercise/Vesting)
Security TypeCommon Stock
Shares Involved24,835
Price Per Share$0.00
Total Value$0 (Compensation)
Shares Owned After161,257
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0 (Non-monetary)
% of Market Cap0.00%
Shares Transacted24,835
% of Shares Outstanding0.002%
Post-Transaction Ownership161,257 shares (0.014% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: With a market capitalization of $17.19 billion, this compensation event is financially immaterial to the company's balance sheet.
  • Ownership Concentration: The insider holds approximately 0.014% of the company, a standard level for a non-executive director.
  • Dilution Impact: The vesting of 24,835 shares represents 0.002% of the 1.15 billion shares outstanding, resulting in virtually zero dilution impact.
  • Transaction Significance: The transaction is purely administrative (vesting of prior awards) and does not reflect a change in the insider's investment sentiment.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a standard compensation event (RSU vesting) common for directors. It does not signal insider confidence (buying) or lack thereof (selling).

Volume & Sentiment

  • Expected Volume Impact: None. The share count is too low to affect liquidity.
  • Sentiment Indicator: Neutral. The insider retained the vested shares rather than selling to cover taxes (based on the filing data provided), which is mildly positive but standard.

Additional Context

Transaction Notes

  • Timing: The transaction occurred on March 6, 2026, related to the vesting of RSUs granted in previous years.
  • Special Circumstances: The filing also includes a new grant of 15,890 RSUs (Code A) which will vest in 2027, ensuring the director's continued alignment with shareholder interests.
  • Dividend Equivalents: A portion of the shares (1,175) were acquired via Dividend Equivalent Units (DEUs), indicating the accumulation of dividends on unvested equity.
Topics:#VTRS#Viatris#SECFiling#Form4#InsiderTrading#PharmaStocks#StockMarket#CorporateGovernance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.